BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20404990)

  • 1. Fuchs' Uveitis: Failure to Associate Vitritis and Disc Hyperfluorescence with the Disease is the Major Factor for Misdiagnosis and Diagnostic Delay.
    Bouchenaki N; Herbort CP
    Middle East Afr J Ophthalmol; 2009 Oct; 16(4):239-44. PubMed ID: 20404990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescein angiographic findings and clinical features in Fuchs' uveitis.
    Bouchenaki N; Herbort CP
    Int Ophthalmol; 2010 Oct; 30(5):511-9. PubMed ID: 20401514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fuchs' Uveitis in Iranian Patients: A Review of 89 Eyes.
    Zarei M; Darabeigi S; Mehrpour M; Roohipoor R; Ghassemi H; Ebrahimiadib N
    Ocul Immunol Inflamm; 2019; 27(7):1077-1085. PubMed ID: 30059646
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical features of Chinese patients with Fuchs' syndrome.
    Yang P; Fang W; Jin H; Li B; Chen X; Kijlstra A
    Ophthalmology; 2006 Mar; 113(3):473-80. PubMed ID: 16458965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When HIV Immunodeficiency and Heterochromia Confuse the Issue: Recurrent Zoster Uveitis Mistaken for Fuchs' Uveitis.
    Papasavvas I; Jeannin B; Herbort CP
    J Ophthalmic Vis Res; 2021; 16(2):295-299. PubMed ID: 34055267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the blood aqueous barrier by measurement of aqueous flare in 31 eyes with Fuchs' heterochromic uveitis with and without secondary open-angle glaucoma].
    Küchle M; Nguyen NX
    Klin Monbl Augenheilkd; 2000 Sep; 217(3):159-62. PubMed ID: 11076346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification Criteria for Fuchs Uveitis Syndrome.
    Standardization of Uveitis Nomenclature (SUN) Working Group
    Am J Ophthalmol; 2021 Aug; 228():262-267. PubMed ID: 33845007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-Widefield Fundus Fluorescein Angiography Findings in Patients with Fuchs' Uveitis Syndrome.
    Nasrollahi K; Fazel F; Mirjani T; Kianersi F; Fazel M; Pourazizi M
    Adv Biomed Res; 2022; 11():1. PubMed ID: 35284352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving Fuchs' uveitis - A diagnostic challenge.
    Kawali A; Sriram R; Srinivasan S; Mahendradas P; Shetty R
    Indian J Ophthalmol; 2024 Jun; 72(6):885-889. PubMed ID: 38317311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients.
    Tugal-Tutkun I; Güney-Tefekli E; Kamaci-Duman F; Corum I
    Am J Ophthalmol; 2009 Oct; 148(4):510-515.e1. PubMed ID: 19477709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with low prevalence of Fuchs' uveitis syndrome in Japan.
    Yoneda Y; Usui Y; Tanaka R; Hase K; Namba K; Kamoi K; Takase H; Takeuchi M; Matsumiya W; Kusuhara S; Takeda A; Yawata N; Yanai R; Hiyama T; Harada Y; Hashida N; Maruyama K; Nakai K; Taguchi R; Kaburaki T; Mizuki N; Goto H; Fujino Y; Takeuchi M
    Front Med (Lausanne); 2022; 9():999804. PubMed ID: 36250082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of retinal microvasculature in Fuchs' uveitis syndrome. Retinal microvasculature in Fuchs' uveitis.
    Aksoy FE; Altan C; Basarir B; Garip D; Pasaoglu I; Perente I; Yigit U; Taskapili M
    J Fr Ophtalmol; 2020 Apr; 43(4):324-329. PubMed ID: 32008841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Fuchs' uveitis syndrome.
    Mohamed Q; Zamir E
    Curr Opin Ophthalmol; 2005 Dec; 16(6):356-63. PubMed ID: 16264346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the disc hyperfluorescence in Fuchs uveitis syndrome using optical coherence tomography imaging.
    Aziz S; Arya B; Westcott M; Pavesio C
    Ocul Immunol Inflamm; 2015 Apr; 23(2):152-6. PubMed ID: 24654676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics of Fuchs' Uveitis Syndrome.
    Nalçacıoğlu P; Çakar Özdal P; Şimşek M
    Turk J Ophthalmol; 2016 Apr; 46(2):52-57. PubMed ID: 27800260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet uveitis.
    Tugal-Tutkun I; Cingü K; Kir N; Yeniad B; Urgancioglu M; Gül A
    Graefes Arch Clin Exp Ophthalmol; 2008 Aug; 246(8):1169-77. PubMed ID: 18504599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuchs' Uveitis: Is It Different from What We Know?
    Özdamar Erol Y; İnanç M; Özdal P
    Ocul Immunol Inflamm; 2022 Jan; 30(1):62-67. PubMed ID: 32835550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to a corneal antigen in Fuchs' heterochromic cyclitis patients.
    van der Gaag R; Broersma L; Rothova A; Baarsma S; Kijlstra A
    Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):443-8. PubMed ID: 2925316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestation of Fuchs uveitis syndrome in childhood.
    Tappeiner C; Dreesbach J; Roesel M; Heinz C; Heiligenhaus A
    Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):1169-74. PubMed ID: 25694152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and prognostic factors in Fuchs' uveitis.
    Al-Mansour YS; Al-Rajhi AA; Al-Dhibi H; Abu El-Asrar AM
    Int Ophthalmol; 2010 Oct; 30(5):501-9. PubMed ID: 20496098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.